Adjuvant aumolertinib in resected EGFR-mutated non-small cell lung cancer: A multiple-center real-world experience

被引：0
|
作者：
Zhang, Q. [1 ]
Ke, L. [1 ]
Huang, S. [2 ]
Yang, Y. [1 ]
He, T. [1 ]
Sun, H. [3 ]
Wu, Z. [1 ]
Zhang, X. [4 ]
Zhang, H. [5 ]
Lv, W. [1 ]
Hu, J. [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Thorac Surg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Thorac Surg, Hangzhou, Peoples R China
[3] Zhejiang Univ, Taizhou Hosp, Dept Thorac Surg, Taizhou, Peoples R China
[4] Wenzhou Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Wenzhou, Peoples R China
[5] Sci Grp Cent Med, Dept Med Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98P
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [21] Safety of osimertinib in EGFR-mutated non-small cell lung cancer
    Mezquita, Laura
    Varga, Andreea
    Planchard, David
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1239 - 1248
  • [22] Systemic treatment of EGFR-mutated non-small cell lung cancer
    Czyzykowski, Rafal L.
    Wrona, Ewa K.
    Talajko, Agata
    Hasinska, Aleksandra M.
    Potemski, Piotr J.
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
  • [23] Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case report
    Lasvergnas, Julie
    Monnet, Isabelle
    Auliac, Jean-Bernard
    Rousseau-Bussac, Gaelle
    Chouaid, Christos
    Assie, Jean-Baptiste
    TRANSLATIONAL LUNG CANCER RESEARCH, 2025, 14 (01) : 287 - 291
  • [24] Adjuvant EGFR-TKI therapy in resected EGFR-mutation positive non-small cell lung cancer: A real-world study
    Liu, Jun-Feng
    Sun, Xu-Sheng
    Yin, Jin-Huan
    Xu, Xi-E
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] Role of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
    Rao, Ding-Yu
    Huang, De-Fa
    Si, Mao-Yan
    Lu, Hua
    Tang, Zhi-Xian
    Zhang, Zu-Xiong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] High-dose furmonertinib in patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastases: A real-world study
    Chen, Haiyang
    Wang, Lili
    Wu, Yingxi
    Wu, Yufeng
    Ma, Shuxiang
    Yang, Sen
    He, Zhen
    Mo, Yuqing
    Zhang, Cuicui
    Wang, Qiming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [27] Furmonertinib as adjuvant therapy in EGFR-mutated non-small cell lung cancer following radical lung cancer surgery
    Zhang, Q.
    Ke, L.
    Xu, J.
    He, C.
    He, T.
    Zhou, Z.
    Lv, W.
    Hu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1550 - S1550
  • [28] Preoperative liquid biopsy for EGFR-mutated detection at diagnostic in early-stage non-small cell lung cancer: real-world experience of a single centre
    Bontoux, Christophe
    Benzaquen, Jonathan
    Taly, Valerie
    Baures, Aurelia
    Allegra, Maryline
    Lacoux, Caroline
    Tanga, Virginie
    Rignol, Guylene
    Berthet, Jean-Philippe
    Marquette, Charles-Hugo
    Lespinet-Fabre, Virginie
    Bordone, Olivier
    Goffinet, Samantha
    Ilie, Marius
    Hofman, Veronique
    Hofman, Paul
    JOURNAL OF CLINICAL PATHOLOGY, 2025,
  • [29] Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India
    Tiwari, Atul
    Singh, Ajay Kumar
    Noronha, Vanita
    Patil, Vijay M.
    Menon, Nandini
    Shah, Minit J.
    Shah, Darshit
    Jobanputra, Kunal
    Trikha, Mehak
    Ubharay, Ahmad
    Yadav, Shashikant
    Majumdar, Anuradha
    Chandrani, Pratik
    Kumar, Rajiv K.
    Pai, Trupti
    Janu, Amit
    Purandare, Nilendu
    Prabhash, Kumar
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
  • [30] Small Cell Lung Cancer Transformation following Treatment in EGFR-Mutated Non-Small Cell Lung Cancer
    Mambetsariev, Isa
    Arvanitis, Leonidas
    Fricke, Jeremy
    Pharaon, Rebecca
    Baroz, Angel R.
    Afkhami, Michelle
    Koczywas, Marianna
    Massarelli, Erminia
    Salgia, Ravi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
12345